OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, et al.
Diabetologia (2022) Vol. 65, Iss. 12, pp. 1925-1966
Open Access | Times Cited: 664
Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, et al.
Diabetologia (2022) Vol. 65, Iss. 12, pp. 1925-1966
Open Access | Times Cited: 664
Showing 1-25 of 664 citing articles:
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
Nikolaus Marx, Massimo Federici, Katharina Schütt, et al.
European Heart Journal (2023) Vol. 44, Iss. 39, pp. 4043-4140
Open Access | Times Cited: 625
Nikolaus Marx, Massimo Federici, Katharina Schütt, et al.
European Heart Journal (2023) Vol. 44, Iss. 39, pp. 4043-4140
Open Access | Times Cited: 625
Type 2 diabetes
Ehtasham Ahmad, Soo Lim, Roberta Lamptey, et al.
The Lancet (2022) Vol. 400, Iss. 10365, pp. 1803-1820
Closed Access | Times Cited: 533
Ehtasham Ahmad, Soo Lim, Roberta Lamptey, et al.
The Lancet (2022) Vol. 400, Iss. 10365, pp. 1803-1820
Closed Access | Times Cited: 533
Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention
Nathan D. Wong, Naveed Sattar
Nature Reviews Cardiology (2023) Vol. 20, Iss. 10, pp. 685-695
Closed Access | Times Cited: 161
Nathan D. Wong, Naveed Sattar
Nature Reviews Cardiology (2023) Vol. 20, Iss. 10, pp. 685-695
Closed Access | Times Cited: 161
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
Juan P. Frías, Srikanth Deenadayalan, Lars Erichsen, et al.
The Lancet (2023) Vol. 402, Iss. 10403, pp. 720-730
Closed Access | Times Cited: 131
Juan P. Frías, Srikanth Deenadayalan, Lars Erichsen, et al.
The Lancet (2023) Vol. 402, Iss. 10403, pp. 720-730
Closed Access | Times Cited: 131
Standards of Specialized Diabetes Care / Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 11th Edition
И. И. Дедов, Marina V. Shestakova, Alexander Yu. Mayorov, et al.
Diabetes Mellitus (2023) Vol. 26, Iss. 2S, pp. 1-157
Open Access | Times Cited: 116
И. И. Дедов, Marina V. Shestakova, Alexander Yu. Mayorov, et al.
Diabetes Mellitus (2023) Vol. 26, Iss. 2S, pp. 1-157
Open Access | Times Cited: 116
Cardiovascular outcomes in type 1 and type 2 diabetes
Annika Rosengren, Pigi Dikaiou
Diabetologia (2023) Vol. 66, Iss. 3, pp. 425-437
Open Access | Times Cited: 78
Annika Rosengren, Pigi Dikaiou
Diabetologia (2023) Vol. 66, Iss. 3, pp. 425-437
Open Access | Times Cited: 78
High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low Threshold
Laurent Castéra, Cédric Laouénan, Anaïs Vallet‐Pichard, et al.
Diabetes Care (2023) Vol. 46, Iss. 7, pp. 1354-1362
Open Access | Times Cited: 71
Laurent Castéra, Cédric Laouénan, Anaïs Vallet‐Pichard, et al.
Diabetes Care (2023) Vol. 46, Iss. 7, pp. 1354-1362
Open Access | Times Cited: 71
An update on peptide-based therapies for type 2 diabetes and obesity
Clifford J. Bailey, Peter R. Flatt, J. Michael Conlon
Peptides (2023) Vol. 161, pp. 170939-170939
Open Access | Times Cited: 69
Clifford J. Bailey, Peter R. Flatt, J. Michael Conlon
Peptides (2023) Vol. 161, pp. 170939-170939
Open Access | Times Cited: 69
Mechanisms and regulation of defensins in host defense
Jie Fu, Xin Zong, Mingliang Jin, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 68
Jie Fu, Xin Zong, Mingliang Jin, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 68
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial
Lori M. Laffel, Thomas Danne, Georgeanna J. Klingensmith, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 3, pp. 169-181
Open Access | Times Cited: 60
Lori M. Laffel, Thomas Danne, Georgeanna J. Klingensmith, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 3, pp. 169-181
Open Access | Times Cited: 60
Synthesis and biological evaluation of indole derivatives containing thiazolidine-2,4-dione as α-glucosidase inhibitors with antidiabetic activity
Chunmei Hu, Bingwen Liang, Jinping Sun, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115957-115957
Closed Access | Times Cited: 57
Chunmei Hu, Bingwen Liang, Jinping Sun, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115957-115957
Closed Access | Times Cited: 57
The Global Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among Patients With Type 2 Diabetes
Zobair M. Younossi, Pegah Golabi, Jillian Kallman Price, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 10, pp. 1999-2010.e8
Closed Access | Times Cited: 55
Zobair M. Younossi, Pegah Golabi, Jillian Kallman Price, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 10, pp. 1999-2010.e8
Closed Access | Times Cited: 55
Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management
Rachel Sinha, Dimitris Papamargaritis, Jack A. Sargeant, et al.
Journal of Obesity & Metabolic Syndrome (2023) Vol. 32, Iss. 1, pp. 25-45
Open Access | Times Cited: 54
Rachel Sinha, Dimitris Papamargaritis, Jack A. Sargeant, et al.
Journal of Obesity & Metabolic Syndrome (2023) Vol. 32, Iss. 1, pp. 25-45
Open Access | Times Cited: 54
Liver disease is a significant risk factor for cardiovascular outcomes – A UK Biobank study
Adriana Roca‐Fernández, Rajarshi Banerjee, Helena Thomaides‐Brears, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 5, pp. 1085-1095
Open Access | Times Cited: 54
Adriana Roca‐Fernández, Rajarshi Banerjee, Helena Thomaides‐Brears, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 5, pp. 1085-1095
Open Access | Times Cited: 54
Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy
Matthias H. Tschöp, Rubén Nogueiras, Bo Åhrén
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1796-1808
Open Access | Times Cited: 51
Matthias H. Tschöp, Rubén Nogueiras, Bo Åhrén
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1796-1808
Open Access | Times Cited: 51
2023 Guidelines on the management of patients with diabetes - a position of Diabetes Poland
Aleksandra Araszkiewicz, Elżbieta Bandurska‐Stankiewicz, Sebastian Borys, et al.
Current Topics in Diabetes (2023) Vol. 3, Iss. 1, pp. 1-133
Open Access | Times Cited: 48
Aleksandra Araszkiewicz, Elżbieta Bandurska‐Stankiewicz, Sebastian Borys, et al.
Current Topics in Diabetes (2023) Vol. 3, Iss. 1, pp. 1-133
Open Access | Times Cited: 48
Identification of 1,3,4-oxadiazolyl-containing β-carboline derivatives as novel α-glucosidase inhibitors with antidiabetic activity
Di Xiao, Li Lu, Bingwen Liang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115795-115795
Closed Access | Times Cited: 45
Di Xiao, Li Lu, Bingwen Liang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115795-115795
Closed Access | Times Cited: 45
Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis
Milena Jancev, Tessa A. C. M. Vissers, Frank L.J. Visseren, et al.
Diabetologia (2024) Vol. 67, Iss. 5, pp. 798-810
Open Access | Times Cited: 33
Milena Jancev, Tessa A. C. M. Vissers, Frank L.J. Visseren, et al.
Diabetologia (2024) Vol. 67, Iss. 5, pp. 798-810
Open Access | Times Cited: 33
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials
Thomas Karagiannis, Konstantinos Malandris, Ioannis Avgerinos, et al.
Diabetologia (2024) Vol. 67, Iss. 7, pp. 1206-1222
Open Access | Times Cited: 25
Thomas Karagiannis, Konstantinos Malandris, Ioannis Avgerinos, et al.
Diabetologia (2024) Vol. 67, Iss. 7, pp. 1206-1222
Open Access | Times Cited: 25
Estimated Sustainable Cost-Based Prices for Diabetes Medicines
Melissa Barber, Dzintars Gotham, Helen Bygrave, et al.
JAMA Network Open (2024) Vol. 7, Iss. 3, pp. e243474-e243474
Open Access | Times Cited: 20
Melissa Barber, Dzintars Gotham, Helen Bygrave, et al.
JAMA Network Open (2024) Vol. 7, Iss. 3, pp. e243474-e243474
Open Access | Times Cited: 20
Waking Up to the Importance of Sleep in Type 2 Diabetes Management: A Narrative Review
Joseph Henson, Alix Covenant, Andrew P. Hall, et al.
Diabetes Care (2024) Vol. 47, Iss. 3, pp. 331-343
Open Access | Times Cited: 19
Joseph Henson, Alix Covenant, Andrew P. Hall, et al.
Diabetes Care (2024) Vol. 47, Iss. 3, pp. 331-343
Open Access | Times Cited: 19
Continuous glucose monitoring for the routine care of type 2 diabetes mellitus
Ramzi Ajjan, Tadej Battelino, Xavier Cos, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 7, pp. 426-440
Closed Access | Times Cited: 18
Ramzi Ajjan, Tadej Battelino, Xavier Cos, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 7, pp. 426-440
Closed Access | Times Cited: 18
Recent advances in the treatment of type 2 diabetes mellitus using new drug therapies
Keong Chong, Jack. Keng-Jui Chang, Lee‐Ming Chuang
The Kaohsiung Journal of Medical Sciences (2024) Vol. 40, Iss. 3, pp. 212-220
Open Access | Times Cited: 16
Keong Chong, Jack. Keng-Jui Chang, Lee‐Ming Chuang
The Kaohsiung Journal of Medical Sciences (2024) Vol. 40, Iss. 3, pp. 212-220
Open Access | Times Cited: 16
Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Acute Coronary Syndrome: A Modern Cinderella?
Paschalis Karakasis, Nikolaos Fragakis, Κωνσταντίνος Κούσκουρας, et al.
Clinical Therapeutics (2024) Vol. 46, Iss. 11, pp. 841-850
Closed Access | Times Cited: 15
Paschalis Karakasis, Nikolaos Fragakis, Κωνσταντίνος Κούσκουρας, et al.
Clinical Therapeutics (2024) Vol. 46, Iss. 11, pp. 841-850
Closed Access | Times Cited: 15
Elective peri‐operative management of adults taking glucagon‐like peptide‐1 receptor agonists, glucose‐dependent insulinotropic peptide agonists and sodium‐glucose cotransporter‐2 inhibitors: a multidisciplinary consensus statement
Kariem El‐Boghdadly, Jugdeep Dhesi, Philippa Fabb, et al.
Anaesthesia (2025)
Open Access | Times Cited: 3
Kariem El‐Boghdadly, Jugdeep Dhesi, Philippa Fabb, et al.
Anaesthesia (2025)
Open Access | Times Cited: 3
